Clyra Medical Technologies


Clyra Medical Technologies is a healthcare company dedicated to improving lives by developing and commercializing innovative products for wound and skin infection treatment. As a subsidiary of BioLargo, Inc., Clyra focuses on creating safe, effective, and cost-efficient solutions that reduce the need for antibiotics and promote wound healing. Their technology, based on a copper-iodine complex, offers a broad-spectrum antimicrobial effect without known microbial resistance, making it suitable for various healthcare settings.

Clyra Medical Logo

Clyra Medical Technologies

3802 Spectrum Blvd, Suite 115, Tampa, FL 33612


What We Do

A highly effective, tissue-safe, long-acting wound irrigation solution for acute and chronic wounds and burns, with no need to rinse out throughout the entire procedure. It is 510(k) cleared by the FDA and offers extremely high antimicrobial activity.

Clyra's copper-iodine complex technology for continued gum health and dental hygiene.

An antimicrobial wound hydrogel dressing for the treatment and protection of chronic and acute wounds, post-surgical wounds, burns, abrasions, and skin irritations.

Clyra technology embedded in super absorbent pads and highly absorbent dressings to manage large quantities of wound exudate, blood, and bodily fluids.

Clyra technology can be impregnated in NPWT dressings and used as an irrigation solution with NPWT systems.

Products for the aesthetic market and post-facial procedures, including facial spritz, post-ablation spray, and acne and scar cream.


Regenerative Medicine


Key People

Chief Executive Officer

Chairman of the Board

Director

Chief Operating Officer

VP Product Development & Innovation

Chief Financial Officer

Chief Medical Officer

Senior Director Markets & Business Development

Director of Quality

Administrative Director

Intellectual Property Strategy Advisor

Associate Director of Product Development

Strategic Partnerships

Legal Advisor - Contracts & Licensing

Brand and Design Advisor


News & Updates

Clyra's first wound management product has received 510(k) clearance from the FDA, marking a significant milestone in their product development.